Lipid-lowering treatment in secondary prevention of ischaemic cerebrovascular disease Elisenda Climent; David Benaiges; Juan Pedro-Botet;

Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study Àlex Vila; Estel Pons; Patricia Trinidad García; Daniel Vidal; Sara López; Armand Grau;

LDL as a therapeutic target Ángel Díaz Rodríguez; Teresa Mantilla Morató;